| |
| |
|
| Insider
Information: |
Gearing David |
| Relationship: |
Chief Scientific Officer |
| City: |
Blackrock |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
13,100 |
|
|
Indirect Shares
|
125,903 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
139,003 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nexvet Biopharma Plc |
NVET |
Chief Scientific Officer |
2016-07-01 |
13,100 |
2016-07-01 |
125,903 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVET |
Nexvet Biopharma Plc |
Chief Scientific Officer |
• – – |
2016-07-01 |
4 |
OE |
$0.13 |
$938 |
D/D |
7,500 |
13,100 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Chief Scientific Officer |
• – – |
2016-07-01 |
4 |
OE |
$0.13 |
$467 |
I/I |
3,733 |
283,063 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
CHIEF SCIENTIFIC OFFICER |
• – – |
2016-03-04 |
4 |
B |
$3.35 |
$30,150 |
I/I |
9,000 |
125,903 |
1.99 |
- |
|
| NVET |
Nexvet Biopharma Plc |
CHIEF SCIENTIFIC OFFICER |
• – – |
2016-03-03 |
4 |
B |
$3.26 |
$6,888 |
I/I |
2,113 |
116,903 |
1.99 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Chief Scientific Officer |
• – – |
2016-02-26 |
4 |
B |
$3.34 |
$40,501 |
I/I |
12,126 |
114,790 |
1.99 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Chief Scientific Officer |
• – – |
2016-02-25 |
4 |
B |
$3.30 |
$62,700 |
I/I |
19,000 |
102,664 |
1.99 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Chief Scientific Officer |
• – – |
2015-11-23 |
4 |
OE |
$0.13 |
$700 |
I/I |
5,600 |
279,330 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Chief Scientific Officer |
• – – |
2015-11-07 |
4 |
OE |
$0.13 |
$1,150 |
I/I |
9,203 |
292,266 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Chief Scientific Officer |
• – – |
2015-11-05 |
4 |
OE |
$0.13 |
$1,151 |
I/I |
9,204 |
273,730 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
CHIEF SCIENTIFIC OFFICER |
• – – |
2015-07-01 |
4 |
OE |
$0.13 |
$467 |
I/I |
3,734 |
264,526 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Chief Scientific Officer |
• – – |
2015-06-08 |
4 |
A |
$0.13 |
$700 |
D/D |
5,600 |
5,600 |
0 |
- |
|
| NVET |
Nexvet Biopharma Plc |
Chief Scientific OfficerOffice |
• – – |
2015-02-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
344,456 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
